Clinical Trial Update: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating potential interactions between SEP-380135 and other drugs in healthy adults, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEP-380135 (SEP-380135)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED